Home > Share Market > Stocks > Kilitch drugs (india) > Financial Statements > KILITCH Key Financial Ratios

Kilitch drugs (india) Financial Statements

Kilitch drugs (india) Key Financial Ratios

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth 28.50 4.52 78 36.50
Op profit growth 2,540 (96) (856) (84)
EBIT growth 153 (62) (166) (20)
Net profit growth 347 (84) (158) (21)
Profitability ratios (%)        
OPM 7.58 0.37 10.30 (2.40)
EBIT margin 8.57 4.36 12 (33)
Net profit margin 5.50 1.58 10.10 (31)
RoCE 4.24 1.88 5.67 (8.80)
RoNW 0.77 0.18 1.21 (2.10)
RoA 0.68 0.17 1.20 (2.10)
Per share ratios ()        
EPS 2.43 0.55 3.75 --
Dividend per share -- -- 0.50 --
Cash EPS 1.15 (0.70) 2.26 (14)
Book value per share 82 76.60 81.60 76.50
Valuation ratios        
P/E 33.40 148 21.20 --
P/CEPS 70.50 (108) 35.10 (3.20)
P/B 0.99 1.06 0.97 0.60
EV/EBIDTA 16.30 31.30 12.40 134
Payout (%)        
Dividend payout -- -- 13.90 --
Tax payout (26) (48) (16) (4.60)
Liquidity ratios        
Debtor days 103 125 126 197
Inventory days 24.40 28.60 19.30 33.20
Creditor days (175) (51) (53) (58)
Leverage ratios        
Interest coverage (7.80) (3.20) -- --
Net debt / equity 0.02 0.08 -- --
Net debt / op. profit 0.44 49.90 (0.70) 2.29
Cost breakup ()        
Material costs (54) (55) (51) (39)
Employee costs (7.60) (11) (8.40) (12)
Other costs (30) (34) (30) (51)

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000